Bryostatin improves survival and reduces ischemic brain injury in aged rats following acute ischemic stroke

BACKGROUND AND PURPOSE: Bryostatin, a potent protein kinase C (PKC) activator, has demonstrated therapeutic efficacy in preclinical models of associative memory, Alzheimer's disease, global ischemia, and traumatic brain injury. In this study, we tested the hypothesis that administration of bryo...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Tan, Zhenjun, Turner, Ryan C., Leon, Rachel L., Li, Xinlan, Hongpaisan, Jarin, Zheng, Wen, Logsdon, Aric F., Naser, Zachary J., Alkon, Daniel L., Rosen, Charles L., Huber, Jason D.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2013
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4041549/
https://ncbi.nlm.nih.gov/pubmed/24172582
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.113.002411
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller